Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
about
The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney diseasePurification and molecular cloning of rat 2-amino-3-carboxymuconate-6-semialdehyde decarboxylaseIndoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injuryTryptophan Metabolism in Patients With Chronic Kidney Disease Secondary to Type 2 Diabetes: Relationship to Inflammatory Markers.A link between central kynurenine metabolism and bone strength in rats with chronic kidney disease.Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysisKynurenine aminotransferase III and glutamine transaminase L are identical enzymes that have cysteine S-conjugate β-lyase activity and can transaminate L-selenomethionineInfluence of adenine-induced renal failure on tryptophan-niacin metabolism in rats.4-Pyridone-3-carboxamide-1-β-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: a biomarker for a toxic NAD analogue in other tissues?New insights into the metabolism of organomercury compounds: mercury-containing cysteine S-conjugates are substrates of human glutamine transaminase K and potent inactivators of cystathionine γ-lyaseTryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study.Nutritional aspect of tryptophan metabolismHigh activity of indoleamine 2,3-dioxygenase is associated with renal insufficiency in Puumala hantavirus induced nephropathia epidemica.Changes in plasma kynurenic acid concentration in septic shock patients undergoing continuous veno-venous haemofiltration.The tryptophan/kynurenine pathway, systemic inflammation, and long-term outcome after kidney transplantation.Gas chromatography/tandem mass spectrometry detection of extracellular kynurenine and related metabolites in normal and lesioned rat brain.Kynurenine aminotransferase 3/glutamine transaminase L/cysteine conjugate beta-lyase 2 is a major glutamine transaminase in the mouse kidney.Contribution of quinolinic acid in the development of anemia in renal insufficiency.A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study.Elevated Levels of Peripheral Kynurenine Decrease Bone Strength in Rats with Chronic Kidney Disease.Clinical Parameters and Gut Microbiome Changes Before and After Surgery in Thoracic Aortic Dissection in Patients with Gastrointestinal Complications.Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells.Metabolomic Alterations Associated with Cause of CKD.Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans.Tryptophan as a surrogate prognostic marker for diabetic nephropathy.Uremic Toxin Clearance and Cardiovascular Toxicities.Diagnostic value of plasma tryptophan and symmetric dimethylarginine levels for acute kidney injury among tacrolimus-treated kidney transplant patients by targeted metabolomics analysis
P2860
Q28382992-32953060-919C-4351-9D45-B8EC64296388Q28579099-4A10EE70-8445-404C-AC8B-458920172AECQ28589204-F2D63635-7DA6-48FF-B9F3-D2CA145FAF59Q33585122-565B36D6-DD70-4FAD-A2EA-A33083E7635EQ33592717-89CFABF9-0BC3-49A3-9C14-737A3280655FQ33648836-12151D5D-7BFE-4B18-B79B-54662F8E289FQ34467450-663BA2DC-809F-4980-BA12-53DEEFEC52D8Q34647405-F7A5A085-0EA4-4853-94FA-8C33659F840FQ35458982-0DD79D58-5289-4F51-AD1E-165634384DDEQ35633926-6A0E1B11-433E-4D4B-99D2-6F2C766DDDD6Q36189171-970EE41A-9D2E-42D3-AA2A-60E056F3A7E0Q37059595-7C16E9D4-AB8B-4ACA-A6FE-DF2C892E92FDQ37416875-29A7CB43-2633-435E-B48C-1074F71BFC6DQ37592913-5DCCB8DA-0ED8-46E2-B804-464EA52ED96BQ38793765-758C9FA2-5C33-4DA0-A192-FF62F1AF15D2Q40924999-0D339837-8D7F-41F2-990D-61D64C7F9C44Q41682621-269549CB-94FE-4C7E-BAA3-679D70D4B1CFQ44350323-30BBAD37-288C-4B38-9657-7C6AFED3EB20Q45387891-7C0582D0-5CE9-4949-8F03-67F8BFD09CDBQ47099897-6937C324-5D7F-45F0-B696-7BAD3C8F8582Q47147664-72AC5315-2DB2-45F1-B791-CADAE5A48431Q47216784-F98E8C49-2447-4CA4-9DD6-49DAE17661EAQ47298005-D51BF887-D6F9-4E5B-9EEB-0D82209E21F7Q47710032-5056FC41-ACEA-40AE-8667-149210C6B403Q48224247-1BEF2E11-2080-43E5-A519-E3657F0758DAQ48226851-48452EF4-6536-425A-8650-92EAA8B17671Q55473173-5DD9DE4B-7BE0-4B9B-AFB4-6354EB97E461Q57050360-98578879-5863-42D0-94C8-9483E585BDCC
P2860
Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
@ast
Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
@en
Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
@nl
type
label
Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
@ast
Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
@en
Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
@nl
prefLabel
Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
@ast
Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
@en
Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
@nl
P2093
P1476
Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
@en
P2093
Fujigaki S
Seishima M
Takemura M
P304
P356
10.1152/AJPRENAL.2000.279.3.F565
P577
2000-09-01T00:00:00Z